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Ya clinical trial under way (clinicaltrials.gov ID: NCT02176265), such surfaces
may offer safe alternatives to DES, particularly in patients in whom rapid healing is
crucial.
CRT-705
Comparison of Biolimus A9-eluting Stent and Zotarolimus-eluting Stent in
Patients with De Novo Coronary Artery Lesion; A Propensity Score-Matched
Analysis
Seung-Woon Rha,1 Byoung Geol Choi,1 Se Yeon Choi,1 Ji Young Park,2 Sang-Ho Park,3
Woong Gil Choi,4 Eun-Gyu Lee,5 Soo Hyun Kim,4 Jihun Ahn,6 Sang Yeub Lee,7
Sang Min Kim,7 Min Woong Kim,8 Seong Gyu Yoon,9 Tae Hoon Ahn,10 Dong Joo Oh1
1Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea, Republic of;
2Cardiology Department, Eulji General Hospital, Seoul, Korea, Republic of; 3Cardiology
Department, Soonchunhyang University Cheonan Hospital, Cheonan, Korea, Republic
of; 4Division of Cardiology, Konkuk University Chungju Hospital, chungju, Korea,
Republic of; 5Cardiovascular Cencer, Andong Sungso Hospital, Andong, Korea,
Republic of; 6Department of Internal Medicine, Soonchunhyang University Gumi
Hospita, Gumi, Korea, Republic of; 7Cardiovascular Center, Chungbuk National
University Hospital, Cheongju, Korea, Republic of; 8Department of Cardiology,
Hanyang University Medical Center, Hanmaeum Hospital, Changwon, Korea, Republic
of; 9Department of Medicine, Korea University Graduate School, Seoul, Korea, Republic
of; 10Gachon University of Medicine and Science, Gil Hospital, Incheon, Korea,
Republic of
BACKGROUND There have been limited data comparing efﬁcacy and safety of Bio-
limus-eluting Stents (BES, BiomatrixTM, Biosensors and NoboriTM, Terumo) with
Zotarolimus-eluting Stent (ZES, Resolute Integrity, Medtronic) in a series of Asian
population in real world clinical practice.
METHODS A total of 626 patients (pts) receiving BES or ZES were pooled from our
prospective percutaneous coronary intervention (PCI) registry from March 2008 to
May 2013. To adjust potential confounders, a propensity score matched (PSM) anal-
ysis was performed using the logistic regression model, and clinical outcomes were
compared between the two groups up to 12-month.
RESULTS After PSM analysis, 2 propensity-matched groups (135 pairs, n ¼ 270 pts,
C-statistic¼0.809) were generated and the baseline characteristics of the two groups
were balanced. At six to 9-month angiographic and Two-year clinical outcomes, there
were similar incidence of binary in-stent restenosis and hard endpoints including
mortality, myocardial infarction, target lesion revascularization (TLR), target vessel
revascularization (TVR), non-target vessel revascularization (NTVR) and major
adverse cardiac events (MACEs,Table).
CONCLUSIONS In our study, BES showed similar efﬁcacy and safety compared with
ZES up to 12-months in a series of Asian population in real world clinical practice.
Table. Mid-term angiographic and 12-month Clinical Outcomes after propensity score matched analysisIMAGING MODALITIES
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BACKGROUND Wave Intensity Analysis (WIA) has found particular applicability in
the coronary circulation where it is able to quantify and qualify the energy affecting
blood ﬂow. The most important wave for the regulation of coronary blood ﬂow is the
backward-travelling decompression wave (BDW). Until now, coronary WIA has always
been calculated from invasive measures of pressure and ﬂow. However, recently it
has become feasible to obtain coronary pressure and ﬂow waveforms non-invasively.
In this study we set out to validate non-invasive coronary wave intensity at rest and
under exercise conditions.
METHOD AND RESULTS 22 patients (mean age 6012, 14 male) with unobstructed
coronary arteries, underwent invasive WIA in the left anterior descending artery.
Immediately afterwards, non-invasive coronary ﬂow and pressure were recorded and
WIA calculated from pulsed-wave Doppler echocardiography and brachial supra-
systolic blood pressure. 9 of these patients also underwent non-invasive WIA
assessment during a standardized exercise regimen.
A consistent pattern of 6 predominating waves were observed both invasively and
non-invasively with a very similar BDW (peak: -13.87.9 vs -14.97.2 x 104 Wm-2s-2,
cumulative -6.54.0 vs -6.22.9 x 103 Wm-2s-1). As has been previously seen inva-
sively, left ventricular hypertrophy was correlated with a decreasing percentage BDW
(r¼-0.52, p¼0.01) and exercise produced a rise in the BDW: at maximum exercise the
peak BDW increased from 10.06.5 to 30.220.4x 104 Wm-2s-2 (p¼0.02) and cumu-
lative from 5.43.8x103 to 14.58.9x103 Wm-2s-1 (p¼0.03).
CONCLUSION Coronary wave intensity analysis can be reliably measured non-inva-
sively and responds appropriately in physiological and pathological settings. This has
potential to simplify WIA assessments and increase its applicability.CRT-707
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BACKGROUND Differentiation of dysfunctional but viable myocardium from irre-
versibly damaged scar tissue has important clinical implications for patients’ ischemic
heart disease and impaired left ventricular function.
METHODS We studied 27 male patients with ischemic cardiomyopathy (Age: 607
years) before and after low dose dobutamine echocardiography (LDDE). Mitral
annular isovolumic contraction velocity (IVV) was obtained from septal, lateral,
anterior and inferior mitral annuli. Wall motion score index (WMSI) was averaged
from 18 segments in apical views. Global viability was considered if enhanced motion
occurred in 2 segments. Difference between post and pre-LDDE IVV and WMSI were
calculated as d-IVV and d-WMSI.
RESULTS 486 segments were assessed. 14 segments were normal, and 472 were
abnormal, of which 67 (14%, 33 basal, 22 mid, and 12 apical) had enhanced motion
post-LDDE. Global WMSI decreased post compared to pre-LDDE (2.330.36 vs.
2.460.21, p¼0.07). IVV increased post-LDDE (6.14.7 vs. 3.71.6 cm/s, p¼0.01). IVV
of different annular positions increased similarly. IVV correlated after LDDE with
global WMSI (r¼ -0.43, p¼0.028), and d-SWMI correlated with d-IVV (-0.43, p¼0.02).
12 patients (44%) showed global viability, for whom d-IVV was higher than patients
without viability (4.1SE 1.17 vs. 1.16SE 0.59 cm/s, p¼0.02). Walls with enhanced
motion had higher d-IVV from the corresponding mitral annular position (4.7SE0.84
vs. 1.9SE0.33 cm/s, p¼0.002) and wall speciﬁc d-WMSI correlated with the d-IVV of
the corresponding mitral annular position (r¼0.43, p<0.001). Post LDDE IVV showed
no signiﬁcant difference when only basal segments showed enhanced motion post
LDDE compared to those who did not (p¼0.134). While, post LDDE IVV was higher
